Prostate-specific antigen

Prostate Cancer Ruben Tinoco Carrington College Prostate Cancer Origin/Overview The prostate is a gland in the male reproductive system, about the size of a walnut and surrounds the urethra. One of its main functions is that it produces a fluid that makes up part of the semen. As men age, the prostate may enlarge and expand, and in the enlarged state, it begins to block the flow of urine. This is a symptom of Benign Prostatic Hyperplasia (BPH) and while not cancerous, surgery is required to

discuss health promotion activities with them, including self-breast exam (SBE) and mammography for the wife and prostate self-exams for the husband. The wife states she is embarrassed to admit she has never done a breast self-exam or had a mammogram and didn't think they were useful anyway. The husband tells you he read in the magazine in your waiting room that blood tests to check for prostate cancer don't need to be done anymore. 1. Briefly describe the technique for doing a SBE. Self-breast exam (SBE)

NON-TECHNICAL SUMMARY Prostate cancer (PCa) is the most common solid malignancy and the second leading cause of cancer death in men, however, a large number of newly diagnosed PCa are indolent. Patients with indolent PCa have to undergo similar treatment as aggressive PCa and suffer from cost and side effect of treatment, compromising the quality of life and potential morbidity without any benefit. FDA has approved Prostate Specific Antigen (PSA) assessment for screening for PCa. However, ubiquitous

Cancer therapy has revolutionized from conventional nonspecific approaches such as surgery, chemotherapy and radiotherapy to a specific method, immunotherapy. Clinical data and results illustrate significant increase in demand for strategies to improve the health of cancer patients. improve immunotherapy during the past two decades because of its major advantages compared to conventional therapies [advantages of immunotherapy to conventional]. Immunotherapy works by integrating immune system to fight

detrimental forms of illness a person can receive. Prostate cancer is cancer that develops in the prostate which is located in the male reproductive system. The cancer spreads from the prostate to other parts of the body including the bones and lymph nodes. Which cause difficultly in urinating, pain in the pelvis or back when urinating, and a person with this illness can experience bloody urine. The majority of people who are diagnosed with prostate cancer are those who are older in age, have a family

Objective The objective of Study 1 (S1) was to review the relationship between antioxidants from diet and supplements and risk of PCa. The antioxidants included were vitamin E, selenium, vitamin C, carotenoids, and polyphenols from coffee and tea. Combination studies were also included. Method The method of S1 was a literature search utilizing the database Pubmed for studies that contained subheadings of diet, antioxidants, and prostatic neoplasms. The reference of selected studies was reviewed

of the most common cancers to be diagnosed in men, prostate cancer has a good prognosis when diagnosed early. Approximately 2.8 million men in the United States have prostate cancer. Raising awareness for this type of cancer is key in being able to detect this cancer early and saving more lives. Definition Prostate cancer begins in the prostate, which is a walnut-shaped gland that is responsible for producing seminal fluid. Some types of prostate cancer grow slowly and may need very little treatment

The key role of testosterone in the growth of prostate cancer was first demonstrated back in 1941 (Huggins, 1941); since then, androgen deprivation therapy (ADT) has provided the mainstay of treatment for patients with hormone-sensitive advanced prostate cancer. Although ADT is palliative, it can normalize serum levels of prostate specific antigen (PSA) in over 90% of patients and can produce objective tumour responses in 80-90%. This antitumor activity can improve quality of life (QOL) by reducing

The most common genitourinary cancers are, renal cell carcinoma of the kidney, transitional cell carcinoma of the bladder, and adenocarcinoma of the prostat. 1- Renal cell carcinoma, the most common cancer of the kidney, accounts for approximately 90% of all renal malignancies. About 65,000 cases of renal cell carcinoma are diagnosed each year in the U.S. Despite advances in diagnosis, especially improved imaging techniques and the incidental diagnosis of many tumors with imaging tests for unrelated

The brochure’s topic on Prostate Cancer Screening is consistent with Healthy People (HP) 2020 objectives on cancer. While the overall objective for all cancers is to “Reduce the number of new cancer cases, as well as the illness, disability, and death caused by cancer” (HP 2020, 2010), the specific objective for prostate cancer is to reduce prostate cancer death rate. The following information demonstrates the intent of the brochure to influence health behavior: a. Prostate cancer as the second leading